Two Sigma Securities
SBFM icon

Two Sigma Securities’s Sunshine Biopharma SBFM Stock Holding History

Two Sigma Securities’s Portfolio SBFM Stock Details SBFM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-117
Closed -$24.4K – 2275
2026
Q1 		$24.4K Buy
+117
New +$27.6K ﹤0.01% 1344
2025
Q4 		– Sell
-86
Closed -$25.6K – 1942
2025
Q3 		$25.6K Buy
+86
New +$25.5K ﹤0.01% 1090
2023
Q2 		– Hold
0
– -$18.5K – 3273
2023
Q1 		– Hold
0
– – – 2374
2022
Q4 		– Hold
0
– -$13K – 3178
2022
Q3 		– Hold
0
– – – 2362
2022
Q2 		– Hold
0
– – – 1945
2022
Q1 		– Hold
0
– – – 1926

Other funds holding SBFM

Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
SBI Securities
SBI Securities Tokyo, Japan $4.38B AUM 56.37% 1-Year Est. Return
National Bank of Canada
National Bank of Canada Montreal, Quebec, Canada $140B AUM 46.34% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $85.1B AUM 27.35% 1-Year Est. Return
Caitong International Asset Management
Caitong International Asset Management Hong Kong $1.04B AUM 150.25% 1-Year Est. Return
Farther Finance Advisors
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
Strive Financial Group
Strive Financial Group Carmel, Indiana $230M AUM
TD Waterhouse Canada
TD Waterhouse Canada Toronto, Ontario, Canada $38.4B AUM 30.28% 1-Year Est. Return

Two Sigma Securities's SBFM Position: Q2 2026 in Review

Two Sigma Securities sold out of Sunshine Biopharma (SBFM) in Q2 2026, closing a stake of 117 shares — an estimated $24.4K sold.

Two Sigma Securities first reported a position in SBFM in Q3 2025 and held it in 2 quarters. The position peaked at $25.6K in Q3 2025. 3 funds tracked by Wall St. Rank hold SBFM as of Q2 2026.

  • Two Sigma Securities reported no remaining Sunshine Biopharma position as of Q2 2026 after selling out during the quarter.
  • Two Sigma Securities sold 117 Sunshine Biopharma shares in Q2 2026, an estimated $24.4K.
  • Two Sigma Securities first reported a position in Sunshine Biopharma in Q3 2025 and held it in 2 quarters.
  • Two Sigma Securities's Sunshine Biopharma position peaked at $25.6K in Q3 2025.
  • 3 funds tracked by Wall St. Rank held Sunshine Biopharma as of Q2 2026.

Based on Two Sigma Securities's 13F filing for Q2 2026, filed 14 Aug 2026.